Report removed., page-66

Another reason why I believe this report is conservative, is that if it plays out in accordance with their projections, Dr G will miss out on his performance shares.

Class B Performance Shares - must achieve revenue of US$30m by May 2019 (based on the report, this still might be achieved).

Class C Performance Shares - must acheive cumulative EBITDA of US$25m by May 2020 (report suggesting cumulative EBITDA will be more like US$6m by this stage).

I really think Dr G will be doing everything in his power to ensure he receives these performance shares, which would blow the reports predictions out of the water.